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Regulation of Transcription by Ubiquitination
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Inactivation of the Transcription Factor Met4
et al., 1999; Kitagawa et al., 1999; Seol et al., 1999;
Skowyra et al., 1999). Cdc34 is the ubiquitin-conjugating
enzyme that is responsible for ubiquitination of most
SCF substrates identified, and Rbx1/Hrt1 recruits Cdc34
to SCF complexes by bridging the Cdc34/Cdc53 interac-
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tion. Among the SCF components and their associatedLa Jolla, California
proteins, it is the F-box protein subunit that confers
substrate specificity. Database searches predict that
there are hundreds of F-box proteins (at least 15 in
yeast alone). Different F-box proteins define distinct SCFSummary
complexes. In budding yeast, three different SCF com-
plexes have been studied in some detail, namely SCFCdc4,Polyubiquitination of proteins by Cdc34/SCF complexes
SCFGrr1, and SCFMet30 (Deshaies, 1999). Whereas most oftargets them for degradation by the 26S proteasome.
the morphological and cell proliferation defects associ-
The essential F-box protein Met30 is the substrate ated with loss of Cdc4 or Grr1 function can be explained
recognition subunit of the ubiquitin ligase SCFMet30. The by inappropriate accumulation of their known target pro-
critical target of SCFMet30 is the transcription factor teins, the essential function of SCFMet30 is not known.
Met4, as deletion of MET4 suppresses the lethality of Temperature sensitive met30 mutants arrest with both
met30 mutants. Surprisingly, Met4 is a relatively stable 1N and 2N DNA content. However, the cell cycle arrest
protein and its abundance is not influenced by Met30. is not due to the known defect in Swe1 degradation,
However, transcriptional repression of Met4 target because deletion of SWE1 does not suppress the lethal-
genes correlates with Cdc34 /SCFMet30-dependent ubi- ity or cell cycle arrest associated with met30 mutation
quitination of Met4. Functionally, ubiquitinated Met4 (Kaiser et al., 1998).
MET30 was initially identified in a screen for S. cerevis-associates with target promoters but fails to form
iae mutants defective in the regulation of genes involvedfunctional transcription complexes. Our data reveal a
in sulfur amino acid metabolism (Thomas et al., 1995).novel proteolysis-independent function for Cdc34/SCF
Specifically, yeast strains harboring a semi dominant-and indicate that ubiquitination of transcription factors
negative allele of MET30 failed to repress MET25 tran-can be utilized to directly regulate their activities.
scription in the presence of high levels of methionine.
Subsequently, it has been demonstrated that this failure
to respond to repressing levels of methionine is due toIntroduction
a defect of Met30 in the context of SCFMet30 because
cdc34, skp1, and cdc53 mutants also fail to repressUbiquitination of proteins plays a major role in regulation
MET25 transcription (Patton et al., 1998). Transcriptionof cellular processes. The best studied function of ubi-
of MET25 and a number of other genes involved in sulfurquitination is its role in protein degradation, where poly-
amino acid metabolism (MET genes) depends on theubiquitinated proteins are recognized by the 26S protea-
transcriptional activator Met4.some and rapidly degraded. However, ubiquitin is also
We show here that inability to downregulate Met4 activ-attached to stable proteins, most notably to a number
ity accounts for the cell cycle arrest phenotype associatedof cell surface receptors, where ubiquitination in re-
with met30 mutants. Mechanistically, Cdc34/SCFMet30-sponse to ligand binding serves as an internalization
mediated ubiquitination of Met4 leads to its inactivation.signal. In either case, ubiquitination of target proteins
Met4 ubiquitination, however, does not induce its degra-is catalyzed by a cascade of enzymatic reactions. Ubi-
dation by the 26S proteasome, but rather results in directquitin is first activated in an ATP dependent step by E1
inhibition of its activity as a transcriptional activator.enzymes, and the activated ubiquitin is then transferred
to a specific cysteine residue on one of a family of ubiqui-
Resultstin-conjugating enzymes (E2). E2 enzymes can directly
ubiquitinate target proteins but often require factors (E3
Deregulation of MET4 Causes Cell Cycle Arrestenzymes or ubiquitin±protein ligases) that confer sub-
in met30 Mutantsstrate specificity. The SCF complexes, probably the best
MET30 is an essential gene in S. cerevisiae. When tem-studied class of E3 enzymes, consist of the three core
perature sensitive met30 mutants are shifted to the re-components Skp1, Cdc53 (in yeast), or Cul-1 (in mam-
strictive temperature, they arrest as both unbudded andmalian cells) and one member of the F-box protein fam-
budded cells with 1N and 2N DNA content, respectivelyily. The F-box protein subunit of SCF directly binds sub-
(Kaiser et al., 1998). It has been reported that deletionstrates (Ciechanover, 1998; Hershko and Ciechanover,
of MET4 bypasses the cell cycle arrest associated with1998; Koepp et al., 1999).
met30 mutations (Patton et al., 1998). We obtained simi-Three other proteins that are important for SCF func-
lar results in our strain background. Tetrad analysis re-tion have been shown to directly associate with SCF
vealed that the double mutant met4 met30 is viablecomplexes, namely Cdc34, Rbx1/Hrt1 and Sgt1 (Kamura
(Figure 1A) whereas the met30 single mutant germinated
but arrested in the first cell cycle as an unbudded (about
70%) or large budded cell (data not shown). Deletion³ To whom correspondence should be addressed (e-mail: sreed@
scripps.edu). of MET4 also suppressed the lethality of temperature
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Met30- and Cdc34-Dependent Modification
of Met4 Correlates with Met4 Activity
The genetic analysis suggested that Met4 is hyperactive
in met30 mutants. Since Met30 is a component of SCF,
which is thought to function exclusively in ubiquitin-
mediated protein degradation, we asked whether Met4
levels were increased in met30 mutants. Met30 was in-
activated in a temperature sensitive met30-6 mutant by
shifting to 378C and we compared levels of myc-epitope
tagged Met4 expressed from the endogenous promoter
in wild-type and met30 mutant cells at 258C and 378C
(Figure 2A). No increase in the level of Met4 was ob-
served in the met30 mutant strain at the restrictive tem-
perature (Figure 2A). However, we observed a dramatic
difference in Met4 modification in wild-type cells and
met30 mutants (Figure 2A). In wild-type cells, Met4 ex-
isted as at least four forms of different mobility (Met4-A,
-B, -C, and -D, respectively). met30 mutants had only
small amounts of Met4-A and -B, but had an additional
distinct Met4 species (Met4-E). The differences in Met4
modification were not caused by the cell cycle arrest
induced in met30 mutants; there was no cell cycle de-
pendent change in Met4 modification during the cell
cycle in a synchronized population of wild-type cells
(data not shown).
These results suggested that Met4 degradation was
Figure 1. Genetic Interaction between MET4, CBF1, and MET30 not defective in met30 mutants, and that the cell cycle
arrest of met30 mutants is not due to accumulation of(A) The mutant strains indicated (Dmet4 (PY518), Dmet4 met30-
6(PY723), and Dmet4 Dmet30 (PY596)) were grown on YEPD plates Met4. This was further supported by our observation
at 258C, replica-plated to fresh plates and the plates were incubated that cells expressing GAL-MET4 did not undergo cell
at the temperatures indicated. cycle arrest (Figure1B) despite having a 10-fold higher
(B) Wild-type cells and temperature sensitive met30-6 mutants ex- level of Met4 than wild type cells or met30 mutants
pressing MET4 under control of the GAL1 promoter (strains PY657 (Figure 2A).
and PY656, respectively) and met30-6 mutants (PY283) were grown
We next asked whether Met4 transactivating activityon YEPD plates at 258C, replica-plated to galactose containing
is upregulated in met30-6 mutants. We analyzed theplates to induce overexpression of MET4 and incubated at 258C.
mRNA levels of three different genes (MET16, MET25,(C) Same as in (A) but with the strains indicated (met30-6(PY283),
and MET28) that are known to be controlled by Met4Dcbf1 (PY640), and Dcbf1 met30-6(PY667)).
activity (Thomas and Surdin, 1997). In methionine-con-
taining medium, expression of MET16, MET25, andsensitive met30-6 mutants at all temperatures tested (Fig-
MET28 is repressed (Thomas and Surdin, 1997). Accord-ure 1A). These genetic results suggest that met30 mutants
ingly, we detected only very low levels of these mRNAsarrest due to hyperactive Met4. Accordingly, overexpres-
in wild-type cells at both 258C and 378C (Figure 2A). Insion of Met4 in temperature sensitive met30-6 mutants,
contrast, MET16, 25, and 28 expression was dere-but not in wild-type cells, resulted in a growth defect
pressed in met30-6 mutants, even in methionine-con-even at permissive temperature (258C) (Figure 1B), sug-
taining medium (Figure 2A). Overexpression of Met4 ingesting that met30 mutants are particularly sensitive to
wild-type cells only modestly derepressed MET16, 25,Met4 levels.
and 28 expression (Figure 2A), suggesting their expres-Met4 is a transcriptional activator that is required for
sion is not regulated at the level of Met4 abundance.expression of many genes involved in sulfur amino acid
We then analyzed Met4 modification during methio-metabolism. The basic helix-loop-helix protein Cbf1 is
nine starvation. Expression of MET genes is repressedanother important transcription factor that acts in con-
in medium containing methionine. However, when me-cert with Met4 in activation of MET genes. Deletion of
thionine is withdrawn, expression is rapidly inducedCBF1 results in a phenotype of methionine auxotrophy,
(Thomas and Surdin, 1997). When we shifted wild-typeslow growth, and chromosome instability (Cai and Davis,
cells to growth medium without methionine we observed1990). Deletion of CBF1 partially suppressed loss of
a rapid change in Met4 modification (Figure 2B). TheMet30 function, as indicated by a higher restrictive tem-
Met4-A and Met4-B forms decreased, whereas Met4-Eperature for cbf1 met30-6 double mutants compared to
accumulated (Figure 2B). This change correlated withmet30-6 single mutants (Figure 1C), indicating that the
Met4 activity as indicated by induction of MET16,lethality of met30 mutants is related to the transcrip-
MET25, and MET28 (Figure 2B). Furthermore, Met4 mod-tional activation function of Met4. However, deletion of
ification in conditions that induce MET gene transcrip-CBF1 could not bypass the requirement for Met30 func-
tion was very similar to Met4 modification in cells lackingtion because the double deletion strain cbf1 met30 was
Met30 function (compare Figures 2A and 2B), sug-inviable (data not shown).
gesting that Met30 is required to downregulate theThese genetic interactions imply that Met30 is re-
transactivating activity of Met4.quired to downregulate Met4 activity and that Met4 in-
It has recently been suggested that components ofduces transcription of a gene, that if hyperinduced,
leads to cell cycle arrest. Cdc34/SCFMet30 are required for proper regulation of MET
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Figure 2. Met4 Modification Depends on
Met30 Activity and Correlates with Met4
Transactivation Activity
(A) Left panel: Wild type cells and met30 mu-
tants expressing MET4 tagged with multiple
copies of the myc-epitope from the endoge-
nous promoter (strains PY725 and PY743)
were shifted to 378C for the time indicated.
Met4-myc was detected by Western blotting
(7.5% gel; loading control: Rpt1). The differ-
ent forms of Met4 are indicated by arrows
and letters. Transcript levels of MET16,
MET25, and MET28 were analyzed by North-
ern blotting (loading control: ACT1). Right
panel: A wild-type strain expressing myc-epi-
tope tagged MET4 under control of the induc-
ible GAL1 promoter (PY742) was grown to
mid-log phase at 308C either under inducing
conditions (YEPG) or repressive conditions
(YEPD) and cell lysates were analyzed as de-
scribed above. For better comparison of Met4
levels, ten times less protein was loaded from
the induced sample. Note that equal amounts
of RNA were loaded for Northern blot
analysis.
(B) Wild-type cells expressing endogenous
MET4-myc (PY725) were grown at 308C to an
OD600 5 0.3 in minimal medium (SD 1 5 mM
methionine) (1met). Cells were washed twice
in SD 2met and incubation at 308C was con-
tinued in SD 2met. Samples were taken after
the time indicated and analyzed as described
in (A).
(C) Wild-type cells and cdc34-3 mutants ex-
pressing endogenous MET4-myc (PY725,
PY754) were grown in YEPD at 258C to an
OD600 5 0.3. The cultures were split into two
and incubation was continued for 2 hr at 258C
and 378C, respectively. Protein and RNA anal-
yses were performed as described in (A).
gene expression (Patton et al., 1998; Seol et al., 1999). Met4 Is a Relatively Stable Protein and Its
Abundance Is Independent of Met30Specifically, cdc34, cdc53, MET30±1, and rbx1/hrt1 mu-
tants are deficient in repression of MET25 expression Met30 is a component of SCF, which together with
Cdc34 plays an important role in processes that lead to(Patton et al., 1998; Seol et al., 1999). Since Met4 modifi-
cation was dependent on Met30 and regulation of MET ubiquitin-mediated protein degradation. Our results that
Met4 was hyperactive but did not accumulate in cdc34gene expression correlated with Met4 modification, we
analyzed Met4 modification in cdc34 mutants. We de- or met30 mutants were, therefore, unexpected (Figure
2). For that reason, we compared the half-life of Met4tected a dramatic change in Met4 modification after
inactivation of Cdc34 (Figure 2C). In contrast, we saw in wild-type cells and met30 mutants. Fully functional
C-terminal myc-epitope-tagged Met4 (Figures 2 and 6)no such change in Met4 mobility in cdc4 mutants defec-
tive in a heterologous SCF complex (Figure 2C), although was expressed for 30 min from the GAL1 promoter in
either wild-type cells or met30 mutants following a shiftthey arrested at the same cell cycle position as cdc34
mutants. Consistent with the strong correlation between to 378C to inactivate the temperature sensitive met30-6
allele. Samples were taken over a period of 100 minMet4 modification and Met4 activity (Figures 2A and B),
MET16, 25, and 28 expression was deregulated in cdc34 after repression of the GAL1 promoter. Western blot
analysis revealed that Met4 degradation was very slowmutants but not in cdc4 mutants (Figure 2C). Taken
together, these results suggest that Cdc34/SCFMet30 ac- and not impaired in met30 mutants (Figure 3A). However,
we noticed a striking change in Met4 modification intivity is required for modification and inactivation of Met4
but not for Met4 degradation. met30 mutants as compared to wild-type cells (Figure
Cell
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Figure 3. Met4 Degradation Is Not Affected
by met30 Mutation
(A) Wild-type cells and met30-6 mutants ex-
pressing C-terminal myc-epitope-tagged Met4
under control of the GAL1 promoter (PY742,
PY760) were grown in raffinose media supple-
mented with 5 mM methionine to an OD600 5
0.3 at 258C, shifted to 378C for 15 min, and
Met4-myc expression was induced by addi-
tion of galactose to a final concentration of
2%. After 30 min, cells were transferred to
prewarmed medium (supplemented with 5
mM methionine) containing 2% dextrose to
repress Met4-myc expression. Samples were
taken at times indicated and analyzed for
Met4-myc levels by Western blotting (7.5%
gel).
(B) Dmet4 (PY793) and Dmet4 Dmet30
(PY794) mutant cells expressing N-terminal
(RGS6H)-epitope- tagged Met4 under control
of the GAL1 promoter were grown in raffinose
media to an OD6005 0.3 at 308C. The cultures
were split into two, collected on filter and
washed with SD media containing 5 mM me-
thionine (ª1metº) or SD media without methi-
onine (ª2metº). Cells were transferred to ga-
lactose (2%) containing media supplemented
with methionine (ª1metº) or without methio-
nine (ª2metº) to induce expression of
(RGS6H)-Met4. After 30min (RGS6H)-Met4
expression was repressed by addition of glu-
cose (2% final) and samples were analyzed
as described in (A).
3A). Rouillon et al. (2000) reported that Met4 is rapidly conditions (Figure 3B), a failure to extract the slower
mobility forms might lead to the conclusion that Met4degraded specifically under repressive conditions (1met)
but stable under nonrepressive conditions (2met). We becomes unstable under these conditions.
had analyzed a full-length Met4 construct containing a
C-terminal myc epitope tag under repressive conditions
(Figure 3A), whereas the construct analyzed by Rouillon Met4 Is Phosphorylated and Ubiquitinated In Vivo
The results described above suggest that Met4 modifi-et al. (2000) had short N-terminal and C-terminal trunca-
tions and was tagged at the N terminus with three HA cation is intimately connected to both Met30 function
and Met4 activity. To establish the nature of the modifiedepitopes. To eliminate the possibility that the difference
arose from the difference in the two constructs, we ana- species, we first asked whether Met4 was phosphory-
lated. Myc-epitope-tagged endogenous Met4 was im-lyzed the degradation of Met4 tagged on its N terminus
with the short (RGS6H)-epitope under repressive and munoprecipitated from wild-type cells and met30 mu-
tants and the immune complexes were treated withnonrepressive conditions (Figure 3B). Similar to the C
terminally myc-tagged Met4, degradation of (RGS6H)- lambda phosphatase. Phosphatase treatment did not
result in any obvious mobility change in Met4 speciesMet4 was slow, and we found no difference in Met4
half-life under repressive (1met) as compared to non- isolated from wild-type cells (Figure 4A). However,
Met4-E, the modification specifically observed in met30repressive conditions (2met) (Figure 3B). Consistent
with our previous results (Figure 2B), Met4 modification mutants, collapsed into form Met4-D upon phosphatase
treatment (Figure 4A), suggesting that Met4-E is a phos-was dramatically different under repressive conditions
as compared to nonrepressive conditions (Figure 3B). phorylated form of Met4.
Met30 is a component of the ubiquitin ligase SCFMet30.We also tested degradation of GAL1 expressed (RGS6H)-
Met4 in met30 deletion strains that were kept alive by Therefore, we asked whether any of the different Met4
species corresponded to ubiquitin conjugates. 63 His-deletion of the endogenous MET4 and observed no dif-
ferences under repressive or nonrepressive conditions tagged ubiquitin was expressed in cells expressing
Met4-myc from the endogenous promoter. Whole cellas compared to wild-type cells (Figure 3B). Similar to
the temperature sensitive met30-6 mutant (Figures 2A lysates were prepared in 6M guanidinium-HCl and ubiq-
uitinated proteins were purified on Ni21 chelate resin.and 3A), Met4-A and Met4-B were absent in these mu-
tants (Figure 3B). We specifically failed to extract Met4-A Lysate preparation in 6M guanidinium-HCl resulted in a
much better preservation of the modified Met4 speciesand Met4-B using the TCA/SDS procedure employed
by Rouillon et al. (2000). Since Met4 gets modified to as compared with conventional lysis procedures. The
majority of Met4 was preserved as slowly migratingforms A and B only in wild-type cells under repressive
Regulation of Transcription by Ubiquitination
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Figure 4. Met4 Is Phosphorylated and Ubiq-
uitinated
(A) Wild-type cells and met30 mutants ex-
pressing endogenous MET4-myc (strains
PY725 and PY743) were grown in YEPD at
308C to an OD600 5 0.3 and shifted to 378C for
2 hr. Immunopurified Met4 was split into three
equal parts. One part was incubated in phos-
phatase reaction mix without phosphatase
(lanes 2 and 5), the second part was incu-
bated with lambda-phosphatase (lanes 3 and
6), and the remaining part was incubated with
lambda-phosphatase and a phosphatase in-
hibitor cocktail (lanes 4 and 7). As a control
sample, immune complexes from wild-type
cells expressing untagged MET4 were treated
with phosphatase (lane 1). Met4 was detected
by Western blotting (7.5% gel).
(B) Wild-type cells expressing untagged or
myc-tagged endogenous MET4 and overex-
pressing 63 His-tagged ubiquitin were lysed
in a buffer containing 6 M guanidinium-HCl
and part of the lysates was separated by
SDS-PAGE (7.5% gel) and Met4 was detected
by Western blotting (lanes 1, 2, and 3). The
remaining lysate was incubated with Ni-NTA-
agarose to purify proteins covalently bound to
63 His-ubiquitin. Ubiquitinated proteins were
detected with a monoclonal antibody di-
rected against ubiquitin (Kaiser et al., 1999;
lanes 4, 5, and 6) and ubiquitinated Met4 was
detected with 9E10 antibodies.
Lanes 1, 4, and 7: strain PY725; lanes 2, 5,
and 8: PY780; lanes 3, 6, and 9: PY781.
Met4-A and Met4-B under these lysis conditions (Figure Met30 in cells expressing endogenous myc-tagged
Met4. As controls, we analyzed cells expressing either4B, lanes 1 and 3). We also detected additional, lower
Gst alone or Gst-tagged Cdc4. We found a small fractionmobility forms of Met4, particularly in lysates from cells
of Met4 (less than 5%) specifically in protein complexesoverexpressing ubiquitin (Figure 4B, lane 3). When we
bound to Gst-Met30 (Figure 5A). Interestingly, Met30analyzed the total pool of ubiquitinated proteins purified
associated only with the nonubiquitinated form of Met4by Ni21 chelate chromatography by immunoblotting with
(Figure 5A).anti-myc antibody, we detected several forms of Met4
The specific physical interaction between Met30 with(Figure 4B, lane 9). Among them were Met4-A, -B, and
Met4 and the loss of ubiquitinated Met4 species in cdc34-C and several more slowly migrating Met4 species (Fig-
and met30 mutants suggested that Cdc34/SCFMet30ure 4B, lane 9). Met4-D was absent from the pool of
directly ubiquitinates Met4. We therefore analyzedubiquitinated proteins (compare lanes 3 and 9 in Figure
whether Met30 was required for Met4 ubiquitination in4B), suggesting that it corresponds to the unmodified
vitro. As substrate for the ubiquitination reaction, weform of Met4, and that Met4-A, -B, and -C and the lower
used immunopurified Met4 from met30 mutants. Onlymobility forms represent Met4 ubiquitin conjugates.
weak ubiquitination of Met4 was detected using partiallyThese experiments demonstrate that Met4 is ubiquiti-
purified SCFMet30, purified E1, and Cdc34. SCFMet30 wasnated in vivo in a Met30-dependent manner. The phos-
purified using Ni-NTA-agarose from yeast cells express-phorylated forms of Met4 migrate with approximately
ing 63 His-tagged Met30 (data not shown). However,the same mobility as the ubiquitinated form Met4-C (Fig-
when we combined whole cell extract prepared fromures 4A and 4B).
met30 mutants with partially purified SCFMet30, Met4 was
efficiently ubiquitinated in an ATP-dependent manner
Met30 Binds Specifically to Met4 and Is Required (Figure 5B, lanes 4, 5, and 6), whereas the extract alone
for Met4 Ubiquitination In Vitro was inactive (Figure 5B, lanes 1, 2, and 3). Furthermore,
F-box proteins confer substrate specificity to SCF com- the pattern of in vitro ubiquitination closely resembled
plexes by directly interacting with substrate proteins that observed in vivo (Figure 3; Figure 5, lanes 4, 5,
and enabling their ubiquitination (Koepp et al., 1999). A and 13). Addition of ªmock-purifiedº SCF, prepared from
physical interaction between Met4 and Met30 has been cells expressing untagged Met30, to met30 mutant ex-
suggested based on a positive two-hybrid interaction tract did not promote Met4 ubiquitination (Figure 5B,
(Thomas et al., 1995). To confirm by biochemical criteria lanes 7 and 8). Taken together, we conclude that Met30
is required for Met4 ubiquitination in vitro.that Met30 and Met4 interact, we expressed Gst-tagged
Cell
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Figure 5. Met30 Binds and Ubiquitinates
Met4
(A) Cells harboring endogenous Met4-myc
and expressing Gst (PY768), Gst-Cdc4
(PY770), or Gst-Met30 (PY769) from the GAL1
promoter were grown in raffinose medium at
308C to an OD600 5 0.3. Expression from the
GAL1 promoter was induced for 40 min by
addition of galactose to a final concentration
of 1%. Proteins were purified on glutathione
beads and analyzed by Western blotting. The
Western blot showing myc-tagged Met4 co-
purifying with Gst-Met30 on glutathione
beads was exposed for a longer period as
compared to the other blots.
(B) Extracts prepared from met30-6 mutants
(PY286) fortified with yeast E1, Cdc34, ubiqui-
tin, and an ATP regenerating system (except
lane 6) were incubated at 308C for the period
indicated (lanes 1, 2, and 3). Partially purified
SCFMet30 (lanes 4, 5, and 6) or ªmock purified
extractº (lanes 7 and 8) were added to the
reaction mix. In lanes 9±12, reactions includ-
ing yeast E1, Cdc34, ubiquitin, an ATP regen-
erating system, and either partially purified
SCFMet30 (lanes 9 and 10) or ªmock purified
extractº (lanes 11 and12) are shown. As a
reference, Met4-myc detected in a wild-type
cell extract is shown (lane 13). All reactions
were analyzed by Western blotting (7.5% gel).
Met4 Ubiquitination Prevents Cbf1 Accumulation MET25 responded to withdrawal of methionine with
slightly different kinetics (Figure 6A).at MET Promoters
To gain insight into the mechanism by which Met4 ubiq- Surprisingly, Met4 binding to the MET16 and MET25
promoters was constant during the entire time course,uitination regulates MET-gene transcription, we ana-
lyzed binding of Met4 and Cbf1 to several MET-promot- whereas binding of Cbf1 to the same promoter regions
was tightly regulated (Figure 6B). Low levels of Cbf1ers in vivo. Specifically, we evaluated the extent of Met4
and Cbf1 binding to these promoters during a time were bound under transcriptionally inactive conditions
whereas high levels were bound under conditions ofcourse of transcriptional activation and repression. We
grew cells expressing epitope-tagged chromosomal active transcription (Figures 6A and 6B). As predicted
by the lack of transcriptional repression of MET genesversions of MET4 or CBF1 in medium supplemented
with repressing concentrations of methionine. Cells in met30 mutants (Figure 6A), we observed constant
levels of Met4 and, more importantly, Cbf1 associatedwere then shifted to medium lacking methionine, and
samples were withdrawn after 15 and 60 min. The final with MET promoters throughout the time course, irre-
spective of methionine levels in the growth medium (Fig-sample was taken 30 min after re-repression of MET
gene expression by addition of methionine. The samples ure 6C). During the entire time course, we found no
increase in the nuclear fractions of Met4 or Cbf1 in met30were analyzed by chromatin immunoprecipitation assays
(ChIP-assays) (Aparicio et al., 1997; Strahl-Bolsinger et mutants as compared to wild-type cells (data not
shown).al., 1997; Tanaka et al., 1997) to assess Met4 and Cbf1
association with the MET promoters in vivo and by The results described above suggest that methionine
levels in the growth medium regulate the ability of Met4Northern blotting to examine the extent of transcription
from these promoters. to recruit Cbf1 to MET promoters and consequently acti-
vate MET gene expression. Consistent with this hypoth-As expected, MET16 and MET25 transcription was
tightly regulated in response to methionine levels in wild- esis, we detected a low and constant level of Cbf1 bind-
ing to the MET16 promoter and the MET25 promoter intype cells and constitutively derepressed in met30 mu-
tants (Figure 6A). Deletion of MET4 abolished expression met4 mutants during the activation/rerepression time
course (Figure 6C).of both MET16 and MET25, whereas Cbf1 was strictly
required for MET16 expression but less important for To evaluate the extent of Met4 ubiquitination during
the activation/rerepression time course, we analyzedMET25 expression (Figure 6A). Interestingly, MET16 and
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Figure 6. Met4 Ubiquitination Regulates Cbf1 Recruitment to MET Promoters
Cells were grown in SD medium supplemented with 5 mM methionine at 258C to an OD600 5 1, washed in SD 2met and incubated (in SD
2met) at 308C. Samples were taken at 0, 15, and 60 min after cells were shifted to SD 2met. After the 60 min sample was taken, MET gene
expression was repressed by addition of methionine to a final concentration of 5 mM and incubation was continued for 30 min. Strains: wild
type: Met4-myc (PY725) Cbf1-HA (PY753); met30-6: Met4-myc (PY743) Cbf1-HA (PY775); Dcbf1 Met4-myc (PY771); Dmet4 Cbf1-HA (PY773).
(A) Northern blot analyses of MET16 and MET25 expression. MET16 and MET25 levels were quantitated by PhosphoImager and ImageQuant
v1.2 software, normalized to ACT1. (B and C) CHIP analyses of Met4 and Cbf1 binding to MET promoters. Met4-myc and Cbf1-HA immune
complexes were washed, eluted, and DNA/protein cross-linking was reversed. PCR was performed on purified DNA with primers amplifying
z250 bp of the MET16 promoter, MET25 promoter, and a control fragment on chromosome XVI. Control PCR reactions were performed on
DNA from cell lysates before immunoprecipitation (WCE) and immune complexes purified from strains with untagged Met4 or Cbf1 (ªuntaggedº).
PCR products were quantitated with NIH-Image software normalized to the untagged control.
(D) Regulation of Met4 ubiquitination. Culture conditions were as described above, but cells were shifted to 378C instead of 308C (PY752 (wt),
PY751 (met30±6)). The chromatin fraction of the formaldehyde cross-linked samples was sonicated, after reversion of the cross-linking analyzed
by Western blotting (7.5% gel; loading control: Orc3).
the samples by Western blotting. Serendipitously, the Ubiquitinated Met4 Binds to the MET25 Promoter
but Shows Reduced Binding to Cbf1 In Vitroprotein extraction conditions used in the ChIP assay
procedure resulted in excellent preservation of ubiquiti- Although the amount of Met4 bound to MET promoters
was constant (Figure 6), it was possible that the variousnated forms of Met4. Presumably, deubiquitination dur-
ing extraction was blocked, allowing a better assess- forms of Met4 have different affinities for the promoters.
We therefore directly tested binding of Met4 to a MET25ment of the Met4 ubiquitination state in vivo. Whereas
the majority of Met4 is ubiquitinated under repressive promoter fragment. Cell lysates prepared from wild-type
cells expressing endogenous Met4-myc and Cbf1-HAconditions (1met), a shift toward unubiquitinated forms
occurred in response to methionine withdrawal in wild- were incubated with a biotinylated MET25 promoter
fragment. We then purified the promoter fragment ontype cells (Figure 6D). In met30 mutants, where MET
gene transcription is constitutively active, the entire pool strepavidin beads and analyzed associated proteins by
Western blotting. Cbf1 and all forms of Met4 bound toof Met4 was in the unubiquitinated form. This suggested
that the nonubiquitinated forms of Met4 (Met4-D and -E) the MET25 promoter (Figure 7A). We detected no bias
for any of the various forms of Met4, suggesting thatare transcriptionally active whereas the ubiquitinated
forms are inactive, as predicted by earlier experiments Met4 association with MET promoters is not regulated
by ubiquitination.(Figure 2).
Taken together, these results suggest that ubiquitina- Since the results obtained in the ChIP assays strongly
suggested that ubiquitination of Met4 prevents Cbf1tion of Met4 prevents Cbf1 association with the pro-
moter regions at levels sufficient to promote tran- association with MET promoters, we directly analyzed
Cbf1/Met4 protein interaction. We incubated recombi-scription.
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specific interaction of Cbf1-HA with Gst-Cbf1 (data not
shown).
This experiment demonstrated that interaction of
Met4-A with Cbf1 was dramatically and specifically re-
duced, whereas the other ubiquitinated forms of Met4
(Met4-B and C) associated with Cbf1. These results are
consistent with our findings that ubiquitination of Met4
correlates with low Cbf1 binding at MET promoters in
vivo (Figure 6). However, since the Cbf1/Met4-A interac-
tion was specifically impaired, we would expect that
Met4-A is the inactive form of Met4 and that the majority
of Met4 should be fully ubiquitinated under fully re-
pressed conditions. Although it is very difficult to pre-
serve the ubiquitinated forms of Met4 during cell lysis
and extract preparation due to nonspecific deubiquitina-
tion, using protein extraction methods that minimize
nonspecific loss of ubiquitination, we find that the major-
ity of Met4 is indeed in the inactive Met4-A form (Figure
7C). This validates the biological significance of the
Cbf1/Met4 binding studies described above.
Discussion
A Proteolysis-Independent Function for Cdc34/SCF
The results presented in this report suggest a degra-
dation-independent, regulatory function for Cdc34/
SCFMet30. Our data indicate that the transcriptional acti-
vator Met4 is ubiquitinated in a Cdc34/ SCFMet30-depen-
dent manner and that ubiquitination of Met4 results in
its inactivation. Analysis of events at Met4-regulated
promoters during activation and rerepression of tran-
scription indicated that Met4 ubiquitination inhibits re-
cruitment of heterologous transcription factors that are
required for MET gene expression. Thus, Cdc34/ SCFMet30-
dependent ubiquitination of Met4 appears to regulate
Figure 7. In Vitro Binding of Met4 to the MET25 Promoter and to the assembly of active transcriptional complexes at MET
Cbf1 promoters.
These results were quite unexpected, as Cdc34/SCF(A) All forms of Met4 bind to the MET25 promoter: Extracts prepared
from cells expressing endogenous Met4-myc and Cbf1-HA (PY752) function has been exclusively implicated in ubiquitina-
were incubated with biotinylated MET25 promotor fragments or a tion of proteins that are subsequently degraded by the
biotinylated control DNA. The biotinylated DNA fragments were puri- 26S proteasome. However, regulatory proteolysis-inde-
fied on strepavidin beads and associated proteins were analyzed pendent functions of ubiquitination have been pre-
by Western blotting (7.5% gel). viously described (Hicke, 1999). The results strongly
(B) Two micrograms of purified recombinant Gst-Cbf1 bound to
suggest that regulation of Met4 by Cdc34/SCFMet30-glutathione beads was used in the binding studies. Yeast cells ex-
mediated ubiquitination is independent of proteolysis.pressing endogenous Met4-myc and Cbf1-HA (PY752) were grown
Protein half-life experiments showed that Met4 is a sta-in SD medium (15 mM methionine) to an OD600 5 0.4, washed with
ble protein and Met4 was not stabilized in met30 mu-SD 2met and incubated 60min in SD 2met (ª2metº sample). MET
gene expression was repressed by addition of methionine to a final tants although Met4 ubiquitination was impaired (Figure
concentration of 5 mM and incubation was continued for 30 min 3). Similarly, Met4 ubiquitination was inhibited when
(ª1metº sample). Cell lysates were incubated with Gst-Cbf1 or as Met30 or Cdc34 function was inactivated, yet endoge-
a control, Gst, and bound proteins were analyzed by Western blot- nous Met4 levels did not increase, suggesting that
ting as described in (A). To account for any nonspecific deubiquitina- Cdc34/Met30-dependent ubiquitination does not con-
tion of Met4 during the incubation periods, the supernatant of the tribute to Met4 proteolysis (Figures 2A and 2C). Increas-
binding experiment rather than whole cell lysates were compared
ing Met4 levels by Met4 overexpression did not induceto the Gst-Cbf1 bound fractions.
transcription of MET genes, thus MET gene expression(C) Cells expressing endogenous Met4-myc (PY725) were grown as
was unaffected by Met4 abundance (Figure 2A).described in (B). Cells were spun down and immediately resus-
It was possible that only a small, but relevant pool ofpended in 20% TCA to minimize nonspecific deubiquitination. Cells
were broken in 20% TCA, proteins resolubilized by boiling in 8 M Met4 was controlled by proteolysis, which would not
urea/4% SDS, and analyzed by Western blotting as described in (A). have been reflected in changes in total Met4 levels.
Therefore, we asked whether Met4 proteolysis might be
restricted to MET promoters and, if so, whether local
nant Gst-Cbf1 bound to glutathione beads with cell ly- regulation of Met4 abundance at MET promoters regu-
sates prepared from wild-type cells expressing endoge- lated MET gene transcription. ChIP assays demon-
nous Met4-myc and Cbf1-HA. A small fraction of Met4- strated that Met4 association with MET promoters was
myc (1%±5%) was specifically retained on Gst-Cbf1 constant regardless of the regulatory status of the pro-
beads (Figure 7B). Interestingly, proportionally much moters (Figures 6B and 6C). Hence, proteolysis of the
less Met4-A, the most ubiquitinated form of Met4, inter- MET promoter-associated Met4 pool was not responsi-
ble for transcriptional regulation. Taken together, theseacted with Gst-Cbf1 (Figure 7B). We also detected a
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2A and 2C; Figure 6A) (Patton et al., 1998, Seol et al.,
1999).
In an attempt to understand how Met4 ubiquitination
regulates MET gene transcription, we analyzed the
events at two distinct MET promoters (MET16 and
MET25) during activation and rerepression. Surprisingly,
Met4 binding at both promoters was unchanged during
transcriptional induction and rerepression (Figure 6B).
However, Cbf1 association was tightly correlated with
transcriptional activity and, in an inverse manner, with
Met4 ubiquitination (Figure 6). This suggests that Cbf1
recruitment to MET promoters leads to their activation
Our data are consistent with Met4 acting either to
promote or, in its ubiquitinated form, to inhibit associa-
tion of Cbf1 with the MET promoters. To decide whether
ubiquitinated Met4 functions as an active repressor or
is simply inactive as a transcription factor will require
further investigation.
As pointed out above, Cbf1 is also a component of
the yeast kinetochore. As with MET gene transcription,
kinetochore function appears to be controlled by ubiqui-
tination, in this case, of the kinetochore protein Cbf2. It
Figure 8. Model for Met4 Regulation: Cdc34/SCFMet30-Mediated is therefore possible that recruitment of Cbf1 to the
Ubiquitination of Met4 Leads to Its Inactivation and Repression of kinetochore is regulated by ubiquitination of Cbf2, anal-
MET Gene Expression. ogous to the relationship between Cbf1 and Met4 at
Ubiquitin hydrolases (Ubp) deubiquitinate and activate Met4 which MET promoters. In this regard, it is interesting to note
results in expression of MET genes and a proposed inhibitor of cell that Met4 and Cbf2 share significant primary structure
cycle progression (gene X).
homology over their respective lengths (15% identity)
and, therefore, are likely to have evolved from a common
ancestral protein.
results support the idea that Cdc34/ SCFMet30-mediated Met4 activation and concomitant MET gene expres-
ubiquitination regulates Met4 function in a proteolysis- sion appear to be initiated by a rapid loss of ubiquiti-
independent manner. nated forms of Met4 (Figure 2B and Figure 6) suggesting
Our data do not exclude a nonproteolytic function of that deubiquitination plays an important role. It will be
the 26S or 19S proteasome in regulation of MET gene interesting to learn whether deubiquitination of Met4 is
transcription. It is possible that ubiquitinated Met4 re- regulated or constitutively active. If the latter is the case,
cruits 26S/19S proteasomes and that some as of yet regulation of Cdc34/SCFMet30 activity is likely to be a key
uncharacterized nonproteolytic function of the protea- event in MET gene activation. Such regulation might
some is important for regulation of MET gene expres- occur via direct inhibition of Cdc34/SCFMet30 or by inhibi-
sion. Such a proteolysis-independent function for the tion of the as yet unknown protein kinase that targets
19S proteasome has been postulated in the regulation Met4 for ubiquitination.
of excision repair in budding yeast (Russell et al., 1999).
It is reasonable to assume that other cellular pro- The Cell Cycle Arrest Phenotype of met30 Mutants
cesses regulated by Cdc34/SCF-dependent ubiquitina- We initiated the experiments on Met4 and Cdc34/
tion are independent of proteolysis and that ubiquitina- SCFMet30 in an attempt to elucidate the molecular mecha-
tion directly regulates protein function or association nism that leads to cell cycle arrest in met30 mutants.
with other proteins. Interestingly, the yeast kinetochore Although our experiments led to the identification of a
component Cbf2 has been shown to be ubiquitinated novel mode of transcriptional regulation and a pre-
in a Cdc34 dependent manner (Yoon and Carbon, 1995), viously unknown function for Cdc34/SCF, we learned
yet Cbf2 is a stable protein (Kaplan et al., 1997). Further- little about the basis for the cell cycle arrest phenotype
more, mutations in the SCF component SKP1 or inacti- conferred by met30 mutants. However, the genetic inter-
vation of the SCF associated protein Sgt1 result in high actions and the biochemical studies described in this
levels of chromosome loss, a phenotype that is consis- report clearly demonstrated that hyperactivation of
tent with misregulation of Cbf2 function. It is noteworthy Met4 is an essential event for the cell cycle arrest ob-
that the Met4 coactivator Cbf1 is also a component of served in met30 mutants. An attractive hypothesis is
the kinetochore (see below). that Met4 controls transcription of an unknown gene
(gene X) that induces cell cycle arrest. Loss of Met30
Regulation of Transcription Factors by Ubiquitination function leads to hyperactivation of Met4 and would
Our analyses of Cdc34/SCFMet30-mediated ubiquitination consequently induce constitutive expression of gene X,
of the transcription factor Met4 demonstrated that tran- causing cell cycle arrest. During the unperturbed cell
scriptional activation and repression of MET genes are cycle, Met4 is in an inactive state. However, when methi-
regulated by ubiquitination. Met4 activity correlated with onine is withdrawn from the growth medium, Met4 is
its ubiquitination status (Figures 2 and 6), suggesting transiently activated until MET genes are expressed and
that ubiquitination inhibited Met4 activity but did not methionine biosynthesis restores adequate concentra-
regulate its proteolysis. Consequently, defects in the tions of important methionine metabolites in the cell,
ubiquitination complex required for Met4 ubiquitination notably S-adenosyl methionine (Figure 2B). It is reason-
(Cdc34/SCFMet30) result in constitutively active Met4 able to propose that under conditions where these cen-
tral metabolites have not yet reached sufficiently highleading to constitutive expression of MET genes (Figures
Cell
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Table 1. Yeast Strains Used in This Study
Strain Relevant genotype Source
15Daub a bar1D ura3Dns ade1 his2 leu2-3,112 trp1-1a (Reed et al. 1985)
PY236 a bar1 pep4::URA3 (Kaiser et al. 1999)
PY283 a met30-6::KANR This study
PY401 a GAL1-MET30(RGS6H)::LEU2::KANR met30::KANR This study
pep4::URA3
PY518 a met4::KANR This study
PY589 a met30::KANR met4::KANR This study
PY640 a cbf1::ZEOR This study
PY667 a cbf1::ZEOR met30-6::KANR This study
PY656 a met30-6::KANR GAL1-(RGS6H)-MET4::LEU2 This study
PY657 a GAL1-(RGS6H)-MET4::LEU2 This study
PY723 a met30-6::KANR met4::KANR This study
PY725 a MET4-(18myc)::TRP1 pep4::URA3 This study
PY742 a GAL1-MET4(18myc)::LEU2::TRP1 pep4::URA3 This study
PY743 a met30-6::KANR MET4-(18myc)::TRP1 pep4::URA3 This study
PY751 a met30-6::KANR MET4(18myc)::TRP1 This study
CBF(HA)3::LEU2 pep4::URA3
PY752 a MET4(18myc)::TRP1 CBF1(HA)3::LEU2 pep4::URA3 This study
PY753 a CBF1(HA)3::LEU2 pep4::URA3 This study
PY754 a cdc34-3 MET4(18myc)::TRP1 pep4::URA3 This study
PY760 a met30-6::KANR GAL1-MET4(18myc)::LEU2::TRP1 This study
pep4::URA3
PY768 a 2mGAL1-GST::LEU2 MET4(18myc)::TRP1 pep4::URA3 This study
PY769 a 2mGAL1-GST-MET30::LEU2 MET4(18myc)::TRP This study
pep4::URA3
PY770 a 2mGAL1-GST-CDC4::LEU2 MET4(18myc)::TRP This study
pep4::URA3
PY771 a cbf1::ZEOR MET4(18myc)::TRP1 pep4::URA3 This study
PY773 a met4::KANR CBF1(HA)3::LEU2 pep4::URA3 This study
PY775 a met30-6::KANR CBF1(HA)3::LEU2 pep4::URA3 This study
PY780 a 2mGAL1-63His-UBI::LEU2 pep4::URA3 This study
PY781 a 2mGAL1-63His-UBI::LEU2 MET4(18myc)::TRP1 This study
pep4::URA3
PY793 a Dmet4::KANR GAL1-RGS6H-MET4::LEU2 This study
PY794 a Dmet30::KANR Dmet4::KANRGAL1-RGS6H-MET4::LEU This study
Protein and RNA analyseslevels to sustain cell cycle progression, a transient cell
For Western blot analysis, protein extracts were prepared in RIPA-cycle arrest is induced to safeguard cellular integrity.
buffer (1% deoxycholic acid, 1% Triton-X-100, 0.1% SDS, 250 mMWe suggest that such a cell cycle arrest would be linked
NaCl, 50mM Tris-HCl [pH.7.5], a-Ph [10 mM sodium pyrophosphate,to methionine levels by Met4-dependent expression of
5 mM EDTA, 5 mM EGTA, 50 mM NaF, and 0.1 mM orthovanadate],
a cell cycle inhibitor (encoded by gene X), and hence that and a-Pr [1 mM PMSF, 2mg/ml aprotinin, leupeptin, and pepstatin
expression of gene X is constitutive in met30 mutants, A] if not otherwise stated. Cells were broken with glass beads 3 3
resulting in permanent cell cycle arrest (Figure 8). Mi- 40 s in a FastPrep FP120 (BIO 101/ Savant).
croarray analyses of gene expression in met30 mutants Total RNA isolation and Northern blotting was performed as de-
scribed (Stuart and Wittenberg, 1994). The membrane was hybrid-should help to identify gene X and elucidate the molecu-
ized with radiolabeled probes (HiPrime, Boehringer Mannheim) inlar mechanism of cell cycle arrest in met30 mutants,
buffer H (100 mM sodium phosphate buffer [pH 7.0], 400 mM NaCl,and by inference, in response to methionine starvation.
5 mM EDTA, 1% SDS, 10% dextran sulfate, and 0.1 mg/ml denatured
salmon sperm DNA). Northern blots were analyzed by Phospho-
Experimental Procedures Imaging and ImageQuant software.
Yeast Strains and Methods
The relevant genotypes of the yeast strains used in this study are Analysis of Met4 Turnover
Met4-myc:wild-type cells and met30-6 mutants containing an inte-listed in Table 1. All strains are isogenic to 15DaubD, a bar1D
ura3Dns, derivative of BF264-15D (Reed et al., 1985). All strains grated GAL1-MET4(myc18) allele (PY742, PY760) were grown in
raff/-leu medium (supplemented with 5mM methionine) at 258C towere grown in standard culture media and standard yeast genetic
methods were used (Guthrie and Fink, 1991). an OD600 5 0.3. Cells were then shifted to 378C and after 15 min
galactose was added to a final concentration of 2% to induce theIn most experiments involving protein analyses, strains harboring
a deletion of PEP4 were used. Deletion of PEP4 did not alter Met4 GAL1 promoter. To terminate Met4 expression after 30 min, cells
were collected on filters and transferred to dex/-leu medium (supple-modification or change any other result, however the experiments
were more reliable because nonspecific proteolysis during extract mented with 5mM methionine, prewarmed to 378C) and incubation
was continued at 378C. Extracts were prepared in 50 mM Tris-HClpreparation and immunoprecipitation was decreased in pep4 mu-
tants. (pH.7.5), 150 mM NaCl, 0.2% NP4O, a-Ph, and a-Pr and analyzed
for the amount of Met4-myc by Western blotting (9E10 antibodies).All epitope-tagged proteins were fully functional because the
strains were indistinguishable from their parental strains in all the (RGS6H)-Met4: Dmet4 (PY793) and Dmet4 Dmet30 (PY794) mutant
cells expressing N-terminal (RGS6H)-epitope-tagged Met4 underparameters tested. Details of the construction of plasmids and
strains and primer sequences are available upon request (peterka@ control of the GAL1 promoter were grown in raff/-leu medium to an
OD6005 0.3 at 308C. The cultures were divided into two, collectedscripps.edu).
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on filter and washed with SD media containing 5mM methionine phosphate buffer [pH 7.5], 10 mM HEPES [pH 7.5], 10% glycerol,
250 mM NaCl, 10 mM b-mercaptoethanol, and a-Pr), and 5 ml H2O(ª1metº) or SD media without methionine (ª2metº). Cells were trans-
ferred to galactose (2%) containing media supplemented with 5mM were added and cells were broken by 4 passages through a French
Pressure Cell. Cell debris was spun down for 20 min at 17,000 rpmmethionine (ª1metº) or without methionine (ª2metº) to induce ex-
pression of (RGS6H)-Met4. After 30 min (RGS6H)-Met4 expression (JA20). After filtration through a 0.45 mm filter, the pH was adjusted
to 7.5, imidazole (final concentration 10 mM) was added, and 125was repressed by addition of glucose (2% final) and samples were
analyzed as described above with anti-(RGS4H) antibodies (Qiagen). mg protein was incubated with 200ml Ni-NTA-agarose for 1 hr at
48C. Proteins bound to Ni-NTA-agarose were washed 5 times with
1 ml NM buffer plus 10 mM imidazole. Bound proteins were elutedAnalyses of Met4 Phosphorylation and Ubiquitination
4 times with 200 ml NM buffer plus 250 mM imidazole. The bufferTo analyze the phosphorylation status of Met4, wild type cells and
was changed to YEB buffer (Verma et al., 1997) by 5 cycles of 4-foldmet30-6mutant cells expressing endogenous MET4-myc (strains
concentration and 4-fold dilution in centricon-50. The final proteinPY725 and PY743), and a untagged control strain (PY236) were
concentration was 2 mg/ml for both SCFMet30 and the ªmock-purifica-grown in YEPD at 308C to an OD600 5 0.3. Cultures were shifted to
tionº, indicating that the majority of proteins were nonspecifically378C for 2 hr, protein extracts were prepared in RIPA-buffer plus 5
bound to Ni-NTA-agarose. To prepare Met4 substrate for in vitromM N-ethylmaleimide and Met4-myc was immunoprecipitated from
ubiquitination assays, met30 mutants expressing Met4-myc (PY743)2.5 mg protein with polyclonal antibodies directed against the myc-
were grown at 378C for 3.5 hr. Cells were broken in buffer B150, 15epitope (Santa Cruz Biotechnology). Immune complexes were
mg of protein was incubated with polyclonal antibodies directedwashed twice with 1 ml RIPA buffer, twice with 1 ml RIPA buffer
against the myc epitope (Santa Cruz Biotechnology) and proteinAwithout phosphatase inhibitors (a-Ph), and once in 1 ml 50 mM Tris-
beads for 2 hr at 48C. Immune complexes were washed 2 times withHCl (pH 7.5), 5 mM DTT, and 0.1 mg/ml BSA. Immunopurified Met4
2 ml buffer B150 and 2 times with 1 ml YEB. Met4-substrate boundwas split into three equal parts. One part was incubated in 100 ml
to beads was equally distributed between the in vitro ubiquitinationphosphatase reaction mix (50 mM Tris-HCl [pH 7.5], 5 mM DTT, 0.1
reactions. In vitro ubiquitination reactions contained 5 mM Mg ace-mM EDTA, 0.01% Brij35, and 2 mM MnCl2) without phosphatase.
tate, 1 mg/ml aprotinin, leupeptin and pepstatin A, 1mM DTT, an ATPThe two other parts were incubated with phosphatase reaction mix
regenerating system (Kaiser et al., 1999), 2 mg/ml bovine ubiquitinand 1200 units lambda-phosphatase (NEB), but to one of them a
(Sigma), recombinant Cdc34 (40 mg/ml), purified yeast E1 (15 mg/phosphatase inhibitor cocktail (a-Ph) was added. The reactions were
ml) and, as indicated, 5 mg/ml whole cell extract prepared fromincubated at 308C for 60 min, and the immunocomplexes were
met30-6 mutants, and/or 1 mg/ml partially purified SCFMet30or ªmock-washed with 300 ml RIPA buffer and analyzed by Western blotting
purificationº, respectively. Ubiquitination reactions were incubated(9E10 antibodies).
at 308C for 0 to 60 min, washed with 300 ml buffer NM and Met4-To analyze Met4 ubiquitination in vivo, a strain expressing endog-
substrate was eluted from the proteinA beads by boiling for 5 minenous Met4-myc and 63 His-tagged ubiquitin under control of the
in 23 SDS sample buffer. The reactions were analyzed by Westerninducible GAL1 promoter from a high-copy plasmid (PY781) was
blotting (9E10 antibodies).grown at 308C to an OD600 5 0.3 in raffinose media. As a control,
strains expressing untagged Met4 and 63 His ubiquitin (PY780) or
tagged Met4 but no tagged ubiquitin (PY725) were processed in Chromatin Immunoprecipitation (ChIP) Assay
parallel. 63 His-tagged ubiquitin was expressed for 4 hr and cells Cells were grown in SD medium supplemented with 5 mM methio-
were broken in buffer C (6 M guanidinium-HCl, 50 mM sodium phos- nine at 258C to an OD600 5 1, washed with prewarmed (308C) SD
phate buffer [pH 8.0], 10 mM Tris-HCl [pH 8.0], 300 mM NaCl, a-Pr, medium lacking methionine and incubated in SD (2met) at 308C.
and 5 mM N-ethylmaleimide). 2.75 mg protein extract was incubated Samples were taken at 0, 15, and 60 min. After the 60 min sample
with 50 ml Ni-NTA-agarose and imidazole (final concentration 10 was taken, MET gene expression was repressed by addition of
mM) for 4 hr at 48C. The beads were successively washed with 1 methionine to a final concentration of 5 mM and incubation was
ml each of buffer C 1 20 mM imidazole, buffer D (same as buffer continued for 30 min. ChIP assays were performed by a protocol
C but 8 M urea instead of 6 M guanidinium-HCl) 1 20mM imidazole based on Tanaka et al., 1997 (see http://www.fhcrc.org/labs/
and twice with buffer D adjusted to pH 6.0 1 20 mM imidazole. breeden/Methods/chromatinIP.html) except that after the cells were
Bound proteins were eluted in 200 ml 23 SDS sample buffer and broken and centrifuged, the supernatant was discarded and the
analyzed by Western blotting with the 9E10 antibody to detect Met4 pellet (chromatin fraction) was resuspended in the initial volume of
or antibodies directed against ubiquitin (Kaiser et al., 1999). Lysis buffer. Met4-myc and Cbf1-HA were immunoprecipitated from
an equivalent of 6.75 3 108 cells with polyclonal anti-myc antibodies
(Santa Cruz Biotechnology) or 12CA5 antibodies, respectively. PCRAnalysis of Met30/Met4 Interaction
reactions (15 min 948C, 273[50 s 948C, 1 min 30 s 508C, and 2 minStrains expressing endogenous Met4-myc and harboring either a
728C], 10 min 728C) were performed using HotStartTaq Master MixYEp-GAL1-GST (PY768), YEp-GAL1-GST-CDC4 (PY770), or YEp-
Kit (Qiagen) on 1/6000 of the input (WCE) and 1/60 of the immunopre-GAL1-GST-MET30 (PY769) construct were grown to an OD600 5 0.3
cipitation. PCR primers were used at a concentration of 0.2 mM. Thein raffinose medium at 308C. Galactose was added to a final concen-
primers were designed to amplify a fragment of 266bp [(2370) 2tration of 1% and incubation was continued at 308C for 40 min.
(2125)] of the MET25 promoter, 257 bp [(2278) 2 (222)] and 370bpProtein extracts were prepared in buffer B150 (50 mM HEPES-KOH
of a control fragment on chromosome XVI (within the promoter[pH 7.3], 150 mM NaCl, 10 mM magnesium acetate, 10% glycerol,
region of HFI1). Sequences of the primers are available at request1% Triton X-100, 20 mM b-glycerol phosphate, 1 mM DTT, a-Ph,
from K. F. (karin@scripps.edu). PCR fragments were separated onand a-Pr). DTT concentration was adjusted to a final concentration
a 2.5% agarose gel and visualized by ethidium bromide.of 5 mM and 1 mg protein was incubated for 2 hr at 48C with 50 ml
glutathione-Sepharose. The beads were washed 4 times with 1 ml
B150 1 5 mM DTT, bound proteins were eluted in 150 ml 23 SDS DNA-Affinity Purification
sample buffer and analyzed by Western blotting. Met4 was detected Cells were grown in YEPD to an OD600 5 0.5, shifted to 378C for 2
with 9E10 antibodies, and Gst or Gst-fusion proteins were detected hr, and extracts were prepared from approximately 3 3 107 cells in
with polyclonal antibodies directed against Gst. 23 buffer D1 (buffer D1: 50 mM HEPES [pH 7.5], 0.5 M NaCl, 5 mM
MgCl2, 1 mM DTT, 0.5% Triton X-100, a-Pr, 0.1mM orthovanadate,
and 10mM pyrophosphate). The cleared lysate was diluted 1:10 withMet4 In Vitro Ubiquitination
Extracts for in vitro ubiquitination were prepared from met30-6 mu- buffer D2 (50 mM HEPES [pH 7.5], 5 mM MgCl2, 1 mM DTT, a-Pr,
0.1 mM orthovanadate, and 10 mM pyrophosphate). Five milligramstants (PY286) as described (Kaiser et al., 1998). SCFMet30 was partially
purified from a Dmet30 deletion strain expressing RGS6H-tagged of total protein was incubated with 1 mg/ml either biotinylated PCR
MET25 promoter fragment or a biotinylated PCR control fragment.Met30 from the GAL1 promoter (PY401). An isogenic wild-type strain
expressing untagged Met30 (PY236) was used for the ªmock-purifi- The PCR fragments were obtained with the same primer sequences
as used for the ChIP assay, but the 59 primer was biotinylated. Aftercationº. Cells were grown at 308C in YEPGal to an OD600 5 1.5. To
7.5 ml cell pellet, 12.5 ml 23 buffer NM (13 NM: 50 mM sodium incubation for 2 hr at 48C, 100 ml Strepavidin MagneSphere beads
Cell
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(Promega, 1 mg/ml) were added and incubated for 1 hr at 48C. The became a cyclin: regulated proteolysis in the cell cycle. Cell 97,
431±434.beads were washed 3 times in Buffer D3 (50mM HEPES [pH 7.5],
50 mM NaCl, 5 mM MgCl2, 1 mM DTT, 0.05% Triton X-100, a-Pr, Patton, E.E., Willems, A.R., Sa, D., Kuras, L., Thomas, D., Craig,
0.1 mM orthovanadate, and 10 mM pyrophosphate), eluted in 23 K.L., and Tyers, M. (1998). Cdc53 is a scaffold protein for multiple
SDS sample buffer and analyzed by Western blotting. Cdc34/Skp1/F-box proteincomplexes that regulate cell division and
methionine biosynthesis in yeast. Genes Dev. 12, 692±705.
Met4/Gst-Cbf1 Interaction Patton, E.E., Willems, A.R., Tang, X., Craig, K.L., Thomas, D., and
To express Gst-Cbf1 in E. coli, the CBF1 orf was amplified by PCR Tyers, M. (1998). SCF (Skp1-Cdc53-F-box protein) complexes in
and cloned into the BamH1 site of pGEX-4T2 (Pharmacia). Yeast cell cycle control and metabolism. Yeast Genetics and Molecular
cell lysates were prepared in buffer D3 supplemented with 5 mM Biology Meeting (College Park, Maryland).
EDTA, 5 mM EGTA, and 50 mM NaF. Eight-hundred micrograms
Reed, S.I., Hadwiger, J.A., and Lorincz, A.T. (1985). Protein kinasetotal protein was incubated with 2 mg purified Gst or Gst-Cbf1 bound
activity associated with the product of the yeast cell division cycleto glutathione beads at 48C for 2 hr. Beads were washed 5 times
gene CDC28. Proc. Natl. Acad. Sci. USA 82, 4055±4059.with 1 ml buffer D3, proteins eluted in 23 SDS sample buffer, and
Rouillon, A., Barbey, R., Patton, E.E., Tyers, M., and Thomas, D.analyzed by Western blotting.
(2000). Feedback-regulated degradation of the transcriptional acti-
vator Met4 is triggered by the SCF(Met30)complex. EMBO J. 19,Acknowledgments
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